Skip to main content
Top
Published in: Trials 1/2018

Open Access 01-12-2018 | Research

Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys

Authors: Alice M. Biggane, Lucy Brading, Philippe Ravaud, Bridget Young, Paula R. Williamson

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

There are numerous challenges in including patients in a core outcome set (COS) study, these can vary depending on the patient group. This study describes current efforts to include patients in the development of COS, with the aim of identifying areas for further improvement and study.

Methods

Using the COMET database, corresponding authors of COS projects registered or published from 1 January 2013 to 2 February 2017 were invited via a personalised email to participate in a short online survey. The survey and emails were constructed to maximise the response rate by following the academic literature on enhancing survey responses. Personalised reminder emails were sent to non-responders. This survey explored the frequency of patient input in COS studies, who was involved, what methods were used and whether or not the COS development was international.

Results

One hundred and ninety-two COS developers were sent the survey. Responses were collected from 21 February 2017 until 7 May 2017. One hundred and forty-six unique developers responded, yielding a 76% response rate and data in relation to 195 unique COS (as some developers had worked on multiple COS). Of focus here are their responses regarding 162 COS at the published, completed or ongoing stages of development. Inclusion of patient participants was indicated in 87% (141/162) of COS in the published completed or ongoing stages and over 94% (65/69) of ongoing COS projects. Nearly half (65/135) of COS included patient participants from two or more countries and 22% (30/135) included patient participants from five or more countries. The Delphi survey was reported as being used singularly or in combination with other methods in 85% (119/140) of projects. Almost a quarter (16/65) of ongoing studies reported using a combination of qualitative interviews, Delphi survey and consensus meeting.

Conclusions

These findings indicated that the Delphi survey is the most popular method of facilitating patient participation, while the combination of qualitative interviews, Delphi survey and consensus meetings is the most popular combination of methods. The increased inclusion of patient participants in the development of COS is encouraging, as is the international approach to COS development that some developers are adopting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clarke M, Williamson PR. Core outcome sets and systematic reviews. Syst Rev. 2016;5(1):1.CrossRef Clarke M, Williamson PR. Core outcome sets and systematic reviews. Syst Rev. 2016;5(1):1.CrossRef
2.
go back to reference Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database Syst Rev. 2014;10:Mr000035. Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database Syst Rev. 2014;10:Mr000035.
3.
go back to reference Williamson P. Core outcome sets will improve the quality of obstetrics research. BJOG. 2014;121(10):1196.CrossRef Williamson P. Core outcome sets will improve the quality of obstetrics research. BJOG. 2014;121(10):1196.CrossRef
4.
go back to reference Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JP, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65.CrossRef Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JP, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65.CrossRef
5.
go back to reference Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Obstet Gynecol. 2009;114(6):1341–5.CrossRef Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Obstet Gynecol. 2009;114(6):1341–5.CrossRef
6.
go back to reference Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy. 2012;17(1):1–2.CrossRef Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy. 2012;17(1):1–2.CrossRef
7.
go back to reference Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N. The COMET handbook: version 1.0. Trials. 2017;18(3):280.CrossRef Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N. The COMET handbook: version 1.0. Trials. 2017;18(3):280.CrossRef
8.
go back to reference Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR. Core Outcome Set-STAndards for Development: The COS-STAD recommendations. PLoS Med. 2017;14(11):e1002447.CrossRef Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR. Core Outcome Set-STAndards for Development: The COS-STAD recommendations. PLoS Med. 2017;14(11):e1002447.CrossRef
9.
go back to reference Young B, Bagley H. Including patients in core outcome set development: issues to consider based on three workshops with around 100 international delegates. Res Involvement Engagement. 2016;2(1):25.CrossRef Young B, Bagley H. Including patients in core outcome set development: issues to consider based on three workshops with around 100 international delegates. Res Involvement Engagement. 2016;2(1):25.CrossRef
10.
go back to reference Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Moher D, Schmitt J, Tugwell P. Core Outcome Set–STAndards for reporting: the COS-STAR statement. PLoS Med. 2016;13(10):e1002148.CrossRef Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Moher D, Schmitt J, Tugwell P. Core Outcome Set–STAndards for reporting: the COS-STAR statement. PLoS Med. 2016;13(10):e1002148.CrossRef
11.
go back to reference Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M, Williamson PR. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One. 2014;9(6):e99111.CrossRef Gargon E, Gurung B, Medley N, Altman DG, Blazeby JM, Clarke M, Williamson PR. Choosing important health outcomes for comparative effectiveness research: a systematic review. PLoS One. 2014;9(6):e99111.CrossRef
12.
go back to reference Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One. 2016;11(1):e0146444.CrossRef Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS One. 2016;11(1):e0146444.CrossRef
13.
go back to reference Gorst SL, Gargon E, Clarke M, Smith V, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and identification of gaps. PLoS One. 2016;11(12):e0168403.CrossRef Gorst SL, Gargon E, Clarke M, Smith V, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and identification of gaps. PLoS One. 2016;11(12):e0168403.CrossRef
14.
go back to reference Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, De Wit M, Hazes M, Richards P, Saag K, Suarez-Almazor M. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34(5):1174–7.PubMed Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, De Wit M, Hazes M, Richards P, Saag K, Suarez-Almazor M. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34(5):1174–7.PubMed
15.
go back to reference Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012;13(1):1.CrossRef Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials. 2012;13(1):1.CrossRef
16.
go back to reference Gargon E, Williamson PR, Young B. Improving core outcome set development: qualitative interviews with developers provided pointers to inform guidance. J Clin Epidemiol. 2017;86:140–52.CrossRef Gargon E, Williamson PR, Young B. Improving core outcome set development: qualitative interviews with developers provided pointers to inform guidance. J Clin Epidemiol. 2017;86:140–52.CrossRef
17.
go back to reference SurveyMonkey LLC. SurveyMonkey®. Palo Alto: SurveyMonkey, LLC; 2012. SurveyMonkey LLC. SurveyMonkey®. Palo Alto: SurveyMonkey, LLC; 2012.
Metadata
Title
Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys
Authors
Alice M. Biggane
Lucy Brading
Philippe Ravaud
Bridget Young
Paula R. Williamson
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2493-y

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue